Alternative nutritional cancer therapies

Authors
Citation
S. Weitzman, Alternative nutritional cancer therapies, INT J CANC, 1998, pp. 69-72
Citations number
31
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF CANCER
ISSN journal
00207136 → ACNP
Year of publication
1998
Supplement
11
Pages
69 - 72
Database
ISI
SICI code
0020-7136(1998):<69:ANCT>2.0.ZU;2-H
Abstract
Increasing attention is being paid to the role of nutrition in cancer. Diet ary measures, such as decreased consumption of calories, fat, alcohol and s moked or pickled foods have been shown to reduce the incidence of specific "adult" cancers, while increased dietary fiber appears to have a protective role. However, no clear scientific evidence exists that dietary manipulati on is a successful primary therapy for established cancer. A significant pe rcentage of adult and child cancer patients take unproven therapies during their illness. Alternative nutritional therapies, of which there is a wide variety, are the commonest of these reflecting current public interest in " natural" remedies. The efficacy and potential toxicity of commonly utilized dietary therapies are here reviewed, in particular the macrobiotic philoso phy, the Gerson diet, the Livingstone diet, and the use of vitamin and mine ral therapy. While details may differ, most alternative approaches involve fresh whole foods, with strong emphasis on low-fat vegetarian diet. Most ar e nutritionally adequate, at least for adults. No anti-cancer diet has been shown to cure established cancers, even those whose incidence is decreased by dietary changes. Careful dietary manipulation may at least improve qual ity of life for adult cancer patients, and, together with conventional ther apy, may prolong survival in selected cancer patients. Assessment by carefu lly controlled prospective clinical trials is essential; those in pediatric patients must be controlled very strictly, since tumors in children have n ot been shown to be influenced by diet, and the diets described may be inad equate for children with malignant disease. (C) 1998 Wiley-Liss, Inc.